FeedworthyAI
Back to feed
GEN – Genetic Engineering and Biotechnology Newsnews

Syngene Expands Integrated Drug Development and Manufacturing Services with BMS

Tuesday, September 22, 2026John SterlingView original

The collaboration between Syngene and Bristol Myers Squibb began in 1998, culminating in the establishment of the Biocon Bristol Myers Squibb Research and Development Center, Syngene's first dedicated R&D Center.

The post Syngene Expands Integrated Drug Development and Manufacturing Services with BMS appeared first on GEN - Genetic Engineering and Biotechnology News.